The long term antibody response to CMV gB vaccine, in patients requiring liver or renal transplant

Mise à jour : Il y a 4 ans
Référence : EUCTR2012-002767-95

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The Primary objective is see the antibody levels found months to years after patients entered the randomised placebo-controlled trial of a glycoprotein B vaccine against cytomegalovirus and to have the previous samples retested using new and different methods which have been developed in different labs.


Critère d'inclusion

  • Cytomegalovirus

Liens